<?xml version="1.0" encoding="UTF-8"?>
<p>To ensure participant safety, the independent lab monitor released laboratory results to the study clinician in the event of a new grade 3 or 4 laboratory adverse event (AE), according to the DAIDS Table for Grading the Severity of Adult and Pediatric Adverse Events (version 2.1),
 <xref rid="hep41482-bib-0013" ref-type="ref">13</xref> if the week‐4 HCV viral load declined less than 2 log
 <sub>10</sub> from entry, or if the study clinician requested a laboratory result based on participant signs or symptoms. For new grade‐3 or grade‐4 laboratory AEs, the laboratory test was repeated as soon as possible and preferably within 10 days of the initial blood draw.
</p>
